StockDriftsStockDriftsTop 23 Saturn V Capital Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| AMLX | AMYLYX PHARMACEUTICALS INC | 11.91% | 4.62M | $83.0M | +6.30%(+274.22K) | $9.17(+136.00%) | 2026-06-30 | |
| ALMS | ALUMIS INC | 11.76% | 2.92M | $82.0M | -8.95%(-286.63K) | $7.06(+258.43%) | 2026-06-30 | |
| ABVX | ABIVAX SA | 9.91% | 518.9K | $69.1M | -4.39%(-23.83K) | $19.55(+521.11%) | 2026-06-30 | |
| PCVX | VAXCYTE INC | 7.11% | 852.9K | $49.6M | +3.44%(+28.38K) | $50.29(+15.47%) | 2026-06-30 | |
| IMMX | IMMIX BIOPHARMA INC | 6.89% | 4.66M | $48.0M | +26.12%(+964.84K) | $5.38(+103.85%) | 2026-06-30 | |
| PHVS | PHARVARIS N V | 6.52% | 1.31M | $45.4M | +9.38%(+112.72K) | $23.40(+50.19%) | 2026-06-30 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 5.56% | 160.9K | $38.8M | -1.24%(-2.02K) | $115.90(+112.06%) | 2026-06-30 | |
| CELC | CELCUITY INC | 5.55% | 370.3K | $38.7M | +31.36%(+88.41K) | $38.53(+138.78%) | 2026-06-30 | |
| IRON | DISC MEDICINE INC | 5.5% | 524.7K | $38.4M | +16.63%(+74.80K) | $61.96(+27.25%) | 2026-06-30 | |
| CADL | CANDEL THERAPEUTICS INC | 4.88% | 3.30M | $34.0M | +14.05%(+407.10K) | $5.54(+102.87%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (14 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | +34.62% | +143.96% | — | — | +172.92% |
| Top 20 Holdings Unweighted | +42.07% | +186.75% | — | — | +204.76% |
Saturn V Capital Management LP reports $697.47M in US-listed equity holdings across 23 positions in its most recent 13F filing. Its largest disclosed positions are AMLX (11.9%), ALMS (11.8%) and ABVX (9.9%). The top 20 holdings account for 98.67% of reported assets. Its disclosed equity book has returned +143.96% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Saturn V Capital Management LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Saturn V Capital Management LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1964437). View Saturn V Capital Management LP’s 13F filings on SEC